The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: Candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia
- 30 November 2002
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 30 (11) , 1273-1282
- https://doi.org/10.1016/s0301-472x(02)00905-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13)Oncogene, 2001
- Inhibition of IL-1-Induced IL-6 Production by Synthetic RetinoidsBiochemical and Biophysical Research Communications, 1997
- Phase II Study: Treatment of Non-Hodgkin's Lymphoma With an Oral Antitumor Derivative of Bis(2,6-dioxopiperazine)JNCI Journal of the National Cancer Institute, 1992
- Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.Genes & Development, 1992
- 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRαNature, 1992
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acidThe Lancet, 1990
- Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17Science, 1990
- Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activityJournal of Medicinal Chemistry, 1988